New York Times by Seth Mydans:

Doctors and nurses clustered around the bed of Nguyen Thi Men when she emerged in mid-March from a nine-day coma, urging her to stay alive.

"Breathe, breathe," they said. "Keep trying. Your husband and your children are waiting for you."

She heard them and she tried, although she felt as if she were drowning, she said in an interview this weekend at her home.

10:40:25 PM    comment []  

BBC News by Pallab Ghosh:

The first detailed study of the spread of the Sars virus in Hong Kong has discovered that the death rate among sufferers was much higher than previously estimated.

The World Health Organization (WHO) initially estimated that the death rate from the virus was 5%.

But the new study - the first to be based on a statistically sound sample of 1,425 cases - puts the death rate at one in five (20%).

9:20:13 PM    comment []  

New York Times by Keith Bradsher:

Hong Kong will establish a regional medical surveillance and research center to study SARS and spot future illnesses before they can turn into epidemics, and will ask the neighboring Guangdong Province to cooperate, Hong Kong's leader announced today.

Tung Chee-hwa, the chief executive, said he would ask the Legislative Council for $64 million for research into infectious diseases.

9:32:04 AM    comment []  

New York Times by Andrew Pollack:

Sales of an antiviral drug produced by a small biotechnology company are surging because doctors in China are using it in an attempt to contain the widening outbreak of SARS, company officials said yesterday.

The company, SciClone Pharmaceuticals of San Mateo, Calif., is expected to announce today that sales of its drug, Zadaxin, are likely to triple this quarter, to $15 million.

Zadaxin is approved in China to treat hepatitis B, though it is not approved for use in the United States, Europe or Japan.

9:20:29 AM    comment []  

Reuters via Yahoo:

The outbreak of Severe Acute Respiratory Syndrome, or SARS, which has killed hundreds and infected thousands, mostly in China and Hong Kong, is having an impact on an increasing number of U.S. companies.

Some of the big names claiming that SARS is impacting business: Avon, Kodak, Exon, McDonald's, Toys R Us, United Airlines and Wal-Mart.

-Tim
8:31:04 AM    comment []  

New York Times by Dean E. Murphy with Karen W. Arenson:

The University of California at Berkeley, has taken the unusual step of turning away about 500 summer students from China, Taiwan, Hong Kong and Singapore because of the large number of SARS cases reported in those areas.

University officials said today that the decision was based on advice from the city's health officer and campus health experts.

1:43:04 AM    comment []